Pavithra Srinivas1, Kaitlyn Rivard2. 1. Department of Pharmacy, Cleveland Clinic, 9500 Euclid Ave (Hb-105), Cleveland, OH, 44195, USA. srinivp2@ccf.org. 2. Department of Pharmacy, Cleveland Clinic, 9500 Euclid Ave (Hb-105), Cleveland, OH, 44195, USA.
Abstract
PURPOSE OF REVIEW: The polymyxins are one of the last line antimicrobial classes to retain activity against multidrug-resistant Gram-negative bacilli. However, with the increased use of polymyxins in recent years, reports of resistance have also been increasing. We aimed to describe the mechanisms and occurrence of polymyxin resistance in Gram-negative organisms and propose strategies to overcome resistance. RECENT FINDINGS: The most common mechanism of acquired resistance to the polymyxins is via modification of the bacterial outer membrane lipopolysaccharide. Global epidemiological surveillance studies have reported the occurrence of polymyxin resistance to be most common in Enterobacteriaceae, specifically Enterobacter species and Acinetobacter baumannii. Prevalence of polymyxin-resistant Gram-negative organisms varies significantly by geographical location. Emergence of polymyxin resistance is of great concern, given the limited number of agents available to treat infections caused by multidrug-resistant Gram-negative organisms. Strategies to mitigate the development of polymyxin resistance include dose optimization and using polymyxin agents in combination with other highly active antimicrobial agents.
PURPOSE OF REVIEW: The polymyxins are one of the last line antimicrobial classes to retain activity against multidrug-resistant Gram-negative bacilli. However, with the increased use of polymyxins in recent years, reports of resistance have also been increasing. We aimed to describe the mechanisms and occurrence of polymyxin resistance in Gram-negative organisms and propose strategies to overcome resistance. RECENT FINDINGS: The most common mechanism of acquired resistance to the polymyxins is via modification of the bacterial outer membrane lipopolysaccharide. Global epidemiological surveillance studies have reported the occurrence of polymyxin resistance to be most common in Enterobacteriaceae, specifically Enterobacter species and Acinetobacter baumannii. Prevalence of polymyxin-resistant Gram-negative organisms varies significantly by geographical location. Emergence of polymyxin resistance is of great concern, given the limited number of agents available to treat infections caused by multidrug-resistant Gram-negative organisms. Strategies to mitigate the development of polymyxin resistance include dose optimization and using polymyxin agents in combination with other highly active antimicrobial agents.
Entities:
Keywords:
Colistimethate sodium; Colistin; Multidrug-resistant gram-negative bacilli; Polymyxin B
Authors: Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios Journal: Antimicrob Agents Chemother Date: 2006-09 Impact factor: 5.191
Authors: L A Arroyo; A García-Curiel; M E Pachón-Ibañez; A C Llanos; M Ruiz; J Pachón; J Aznar Journal: J Clin Microbiol Date: 2005-02 Impact factor: 5.948
Authors: Patrick McGann; Erik Snesrud; Rosslyn Maybank; Brendan Corey; Ana C Ong; Robert Clifford; Mary Hinkle; Timothy Whitman; Emil Lesho; Kurt E Schaecher Journal: Antimicrob Agents Chemother Date: 2016-07-22 Impact factor: 5.191
Authors: Shimaa S Elnahriry; Hazim O Khalifa; Ahmed M Soliman; Ashraf M Ahmed; Alaaddin M Hussein; Toshi Shimamoto; Tadashi Shimamoto Journal: Antimicrob Agents Chemother Date: 2016-04-22 Impact factor: 5.191
Authors: Xukai Jiang; Kai Yang; Bing Yuan; Bin Gong; Lin Wan; Nitin A Patil; James D Swarbrick; Kade D Roberts; Falk Schreiber; Lushan Wang; Tony Velkov; Jian Li Journal: J Biol Chem Date: 2020-09-10 Impact factor: 5.157